PLAINSBORO, N.J., Oct. 15, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Tuesday, November 20, 2007 at 3:00 PM Eastern Time at the New York Marriott East Side Hotel in New York City. The meeting, which will be hosted by Stuart Essig, Integra LifeSciences' President and Chief Executive Officer, will feature an overview of our business, a discussion of our products and pipeline, and our strategy for future growth.
The Analyst Forum is open to all analysts and investors. Those who wish to attend the Analyst Forum in person should send an email to the attention of Dorothy Smith (dsmith@Integra-LS.com) by November 14, 2007 requesting a reservation to attend in person. Access to the live presentation will be available by dialing (913) 312-6683 or through a webcast via a link provided on the Investor Relations homepage of Integra's website at www.Integra-LS.com. Listeners participating via telephone or webcast will not be able to ask questions during the question and answer session.
A replay of the Analyst Forum will be accessible starting three hours following the conclusion of the live event. Access to the replay will be available through December 4, 2007 by dialing (719)457-0820 (access code 4930130) or through the webcast.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at (http://www.Integra-LS.com).
Statements made in the upcoming Analyst Forum may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2006 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
IART-G